| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/29/2001 | CN1309999A Yiyuansan powder as one orally taken medicine for treating liver cancer and its preparation |
| 08/29/2001 | CN1309998A Chinese medicine capsule mainly for treating cerebral infraction |
| 08/29/2001 | CN1309996A Deer fetus oral liquid and its preparation |
| 08/29/2001 | CN1309995A Medicine for treating burn, scald, frost bite and wound |
| 08/29/2001 | CN1309994A Pile treating Longzaowan pill |
| 08/29/2001 | CN1309992A Apoplexy curing decoction |
| 08/29/2001 | CN1309991A Chinese herb medicine for treating coronary heart disease |
| 08/29/2001 | CN1309979A Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes |
| 08/29/2001 | CN1309974A Jiangu capsule for strengthening bone |
| 08/29/2001 | CN1309973A Jinchaogankang capsule for treating hepatosis |
| 08/29/2001 | CN1309972A Garter snake capsule |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/29/2001 | CN1070076C Medicine for treating cough & asthma and its producing method |
| 08/29/2001 | CN1070073C Medicine for treating hypercoagulable blood and its preparation |
| 08/29/2001 | CN1070072C Enterelcosis capsule |
| 08/29/2001 | CN1070071C Chinese herb medicine for treating piles and anal fistula |
| 08/29/2001 | CN1070070C Chinese herb medicine for treating gout |
| 08/29/2001 | CN1070066C Chinese herb medicine for cholecystitis |
| 08/29/2001 | CN1070065C Health wine and its making method |
| 08/29/2001 | CN1070064C Method for preparing ointment for curing burns and scalds |
| 08/29/2001 | CN1070063C Powder medicine for reunion of broken bone |
| 08/29/2001 | CN1070059C Medicinal liquor and its prodn. method |
| 08/29/2001 | CN1070056C Process for producing powder composition containing microbe cells of killed butyricin bacterium |
| 08/29/2001 | CN1070055C Deerhorn glue oral liquid |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6281015 Introducing a microsphere with a bioactive factor to a hepatocyte seeded biodegradable polymer matrix into a transplantation site; enhancing survival and proliferation of transplanted cells |
| 08/28/2001 | US6281012 Preventing graft versus host disease |
| 08/28/2001 | US6281010 Gene expression, engineering; packaging transgene; genetic disorders |
| 08/28/2001 | US6281000 Dna fragment cloning into genome of recombinant adenoviral plasmid vector; human gene therapy |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/28/2001 | US6280958 Detecting preferential antibodies in sample; incubate sample with antigenic protein and detect immune complex |
| 08/28/2001 | US6280957 Preventing graft rejection in humans; administer human a modulator of ligand activity, insert hematopoietic stem cells and graft into human, monitor response to grafts |
| 08/28/2001 | US6280774 Extraction of bile from animals, stimulating monocytes and macrophages and modulating tumor necrosis factor production |
| 08/28/2001 | US6280760 Peptide-coated implants and methods for producing same |
| 08/28/2001 | US6280755 To modulate metabolism of lipids in superficial mammalian tissues; in foods, drugs and cosmetics |
| 08/28/2001 | US6280751 For treatment of disease or physical disability or sports injuries, for build up and maintenance of immune system, or for protection against disease or pollution |
| 08/28/2001 | US6280743 Use of mCRP to enhance immune responses |
| 08/28/2001 | US6280729 Treating christmas disease in patient by administering effective amount of therapeutic composition comprising storage stable aqueous solution of purified factor ix |
| 08/28/2001 | US6280724 Composition and method for preserving progenitor cells |
| 08/28/2001 | US6280718 Hematopoietic differentiation of human pluripotent embryonic stem cells |
| 08/28/2001 | CA2178487C Local delivery of fibrinolysis enhancing agents |
| 08/28/2001 | CA2111845C Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060810A1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060391A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | WO2001060388A1 Cell activator |
| 08/23/2001 | WO2001060359A1 Physiologic activity of a benzopyran derivative originating from propolis |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001002030A3 Scaffold matrix and tissue maintaining systems |
| 08/23/2001 | WO2000077177A3 Isolation of a human retrovirus |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016212 Topical mixture of organic chicken and hen herb, organic ruta herb, unsalted butter and pure beeswax; for various skin disorders such as eczema, dryness, itchiness |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | US20010015227 Fluid management systems |
| 08/23/2001 | DE10006822A1 Künstliche Knochenchips, Verfahren zu ihrer Herstellung und ihre Verwendung Artificial bone chips, processes for their preparation and their use |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2399816A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2337574A1 Hematopoietic stem cell expansion enhancing factor and method of use |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1124975A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124633A1 Use of an adsorbent gel for eliminating and purifying biomolecules |
| 08/22/2001 | EP1124593A1 Method for preparing bone material |
| 08/22/2001 | EP1124592A2 Textured and porous silicone rubber |
| 08/22/2001 | EP1124583A1 Adeno-associated vectors for expression of factor viii by target cells |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124575A1 Method for the production of an antiviral agent |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124569A2 Composition and method for increasing weight gain and feed efficiency |
| 08/22/2001 | EP1124542A1 Capsules with porous mineral cortex |
| 08/22/2001 | EP1124428A1 Stromal cell use |
| 08/22/2001 | EP0973383A4 Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0641196B1 Microencapsulation of cells |
| 08/22/2001 | CN1309569A Composition comprising tumor cells and extracts and method for using thereof |
| 08/22/2001 | CN1309552A Pharmaceutical, hygienic and/or cosmetic compositions contg. sea water and uses |
| 08/22/2001 | CN1309180A Multi-mesoblast pedigree differential potency for stromal cell from fatty tissue, and its use |
| 08/22/2001 | CN1309175A Process for preparing three-fungus symbiote and health-care liquid prepared from it |
| 08/22/2001 | CN1308975A Beautifying health-care sheet |
| 08/22/2001 | CN1308963A Anticancer medicine powder |
| 08/22/2001 | CN1308959A Medicine 'Yishenjieyu' for treating mental diseases (psychosis) |
| 08/22/2001 | CN1308958A Medicine 'Huoxuexingshen' for treating mental diseases (psychosis) |
| 08/22/2001 | CN1308957A Chinese medicine for treating mastoplasia and its preparing process |
| 08/22/2001 | CN1308949A Medicine for treating diabetes and its preparing process |
| 08/22/2001 | CN1308947A Drug-dropping tea and its preparing process |